Veeva Systems (NYSE: VEEV) today announced a strategic collaboration with global biotechnology leader Amgen to drive innovation in clinical trials. Under this partnership, Amgen will leverage the Veeva Clinical Platform to optimize end-to-end clinical trial operations, enhance data integration, and accelerate the delivery of novel therapies to patients with serious diseases.
Science Significance
The Veeva Clinical Platform offers an interconnected suite of tools including CTMS, EDC, Clinical Workbench (CDB), RTSM, eCOA, eTMF, Site Connect, and Study Training. By integrating these applications, Amgen can streamline trial design, execution, and data management, enabling faster, more precise clinical insights and supporting the development of advanced therapeutics.
Regulatory Significance
The platform supports regulatory-compliant processes, ensuring robust data integrity, traceability, and audit readiness across all phases of clinical trials. This capability positions Amgen to maintain cGxP compliance, meet global regulatory expectations, and reduce the risk of delays in clinical submissions.
Business Significance
Advertisement
For Veeva, the collaboration reinforces its leadership in providing cloud-based solutions for life sciences, while Amgen benefits from enhanced operational efficiency and standardized clinical processes. The partnership demonstrates the value of digital transformation in clinical research, enabling organizations to accelerate drug development and improve resource utilization across global trials.
Patients’ Significance
By optimizing clinical trial workflows, the collaboration has the potential to shorten development timelines, enabling patients to access innovative, life-saving therapies sooner. Enhanced data management and analytics also support the identification of safer and more effective treatments, improving patient outcomes.
Policy Significance
The partnership exemplifies adoption of advanced digital solutions in life sciences that align with regulatory priorities for data standardization, transparency, and compliance. It highlights how strategic collaborations can help shape policy expectations for clinical trial technology and accelerate innovation responsibly.
Transaction Highlights
Amgen will implement the Veeva Clinical Platform across its clinical operations, supported by Veeva Business Consulting for implementation and change management. The integrated platform will provide connected clinical data applications to optimize trial execution, automate data flow, and improve decision-making. This collaboration underscores both companies’ commitment to driving efficiency, innovation, and patient-centric outcomes in clinical research.
Source: Veeva Systems Press Release
